TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial

• Brigitte Dreno ,

  * E-mail: brigitte.dreno@wanadoo.fr

  Affiliation Department of Skin Cancer, University Hospital, Nantes, France

  ⨯
• Mirjana Urosevic-Maiwald,

  Affiliation Department of Dermatology, University Hospital, Zurich, Switzerland

  ⨯
• Youn Kim,

  Affiliation Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Joan Guitart,

  Affiliation Northwestern University Medical School, Chicago, Illinois, United States of America

  ⨯
• Madeleine Duvic,

  Affiliation University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Olivier Dereure,

  Affiliation Department of Dermatology, Saint Eloi Hospital, Montpellier, France

  ⨯
• Amir Khammari,

  Affiliation Department of Skin Cancer, University Hospital, Nantes, France

  ⨯
• Anne-Chantal Knol,

  Affiliation Department of Skin Cancer, University Hospital, Nantes, France

  ⨯
• Anna Derbij,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Monika Lusky,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Isabelle Didillon,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Anne-Marie Santoni,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Bruce Acres,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Vincent Bataille,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Marie-Pierre Chenard,

  Affiliation Department of Pathology, University Hospital, Strasbourg, France

  ⨯
• Pascal Bleuzen,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
• Jean-Marc Limacher,

  Affiliation Transgene, Illkirch (Strasbourg), France

  ⨯
•  [ ... ],
• Reinhard Dummer

  Affiliation Department of Dermatology, University Hospital, Zurich, Switzerland

  ⨯
• [ view all ]
• [ view less ]